These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 79304)
1. [Value of alpha-globulin as a biological tracer in urogenital cancer]. Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA Actas Urol Esp; 1978; 2(3):119-26. PubMed ID: 79304 [No Abstract] [Full Text] [Related]
2. [Value of alpha-2 globulin, as a biological tracer in the urothelial carcinoma]. Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA Arch Esp Urol; 1978; 31(3):225-34. PubMed ID: 80976 [TBL] [Abstract][Full Text] [Related]
3. Immunologic features of genitourinary cancer. Javadpour N Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366 [No Abstract] [Full Text] [Related]
4. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)]. Hering H; Hering FJ; Weidner W Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894 [TBL] [Abstract][Full Text] [Related]
5. Immunology of genitourinary tumors. Guinan P; Sadoughi N; Bush IM; John T; Eghrari F; Ablin RJ Urology; 1973 Nov; 2(5):493-9. PubMed ID: 4131868 [No Abstract] [Full Text] [Related]
6. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract. Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212 [No Abstract] [Full Text] [Related]
7. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer]. Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test. Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555 [No Abstract] [Full Text] [Related]
10. Concanavalin A-activated suppressor cell activity in peripheral blood lymphocytes of urologic cancer patients. Catalona WJ; Ratliff TL; McCool RE J Natl Cancer Inst; 1980 Sep; 65(3):553-7. PubMed ID: 6157855 [TBL] [Abstract][Full Text] [Related]
11. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract]. Rost A; Kneppenberg U; Rost P Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865 [TBL] [Abstract][Full Text] [Related]
12. [Urological cancer: treatment strategies]. Srougi M; de Góes GM AMB Rev Assoc Med Bras; 1983; 29(11-12):199-209. PubMed ID: 6369432 [No Abstract] [Full Text] [Related]
13. The cancer associated antigen test as an index to failure of complete removal of urological cancers. Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503 [No Abstract] [Full Text] [Related]
14. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors. Mostofi FK; Sesterhenn I Natl Cancer Inst Monogr; 1978 Dec; (49):133-41. PubMed ID: 571042 [TBL] [Abstract][Full Text] [Related]
15. [Immunochemical studies of tissue alpha2 globulin in neoplastic and normal tissues of human kidney]. Prokopenko PG; Tatarinov IuS Biull Eksp Biol Med; 1973 Aug; 76(8):102-5. PubMed ID: 4130348 [No Abstract] [Full Text] [Related]